tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PYPD Stock Latest News

PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst SHIELD II Trial Progress and Strategic FDA Engagement
RatingsPolyPid’s Promising Outlook: Buy Rating Affirmed Amidst SHIELD II Trial Progress and Strategic FDA Engagement
1M ago
PYPD
PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention
PremiumCompany Announcements
PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention
1M ago
6K
PYPD
PolyPid completes enrollment in SHIELD II Phase 3 trial for D-PLEX100
PremiumThe Fly
PolyPid completes enrollment in SHIELD II Phase 3 trial for D-PLEX100
1M ago
PYPD
PolyPid Ltd. Earnings Call Highlights Promising Prospects
PremiumCompany Announcements
PolyPid Ltd. Earnings Call Highlights Promising Prospects
2M ago
PYPD
PolyPid Ltd. Reports Positive Trial Progress and Financial Outlook
PremiumCompany Announcements
PolyPid Ltd. Reports Positive Trial Progress and Financial Outlook
2M ago
PYPD
PolyPid Updates: New Board Appointment and SHIELD II Trial Progress
PremiumCompany AnnouncementsPolyPid Updates: New Board Appointment and SHIELD II Trial Progress
2M ago
6K
PYPD
PolyPid reports Q4 EPS ($1.13), consensus (88c)
Premium
The Fly
PolyPid reports Q4 EPS ($1.13), consensus (88c)
2M ago
PYPD
PolyPid sees runway into 3Q25
Premium
The Fly
PolyPid sees runway into 3Q25
2M ago
PYPD
PolyPid provides corporate update
PremiumThe Fly
PolyPid provides corporate update
2M ago
PYPD
PYPD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PYPD Earnings this Week: How Will it Perform?
2M ago
PYPD
PolyPid initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
PolyPid initiated with a Buy at Rodman & Renshaw
2M ago
PYPD
PolyPid files to sell 11.23M ordinary shares for holders
PremiumThe Fly
PolyPid files to sell 11.23M ordinary shares for holders
3M ago
PYPD
PolyPid Regains Nasdaq Compliance with Private Placement Boost
PremiumCompany AnnouncementsPolyPid Regains Nasdaq Compliance with Private Placement Boost
3M ago
6K
PYPD
PolyPid Advances Phase 3 Trial and Secures Financing
Premium
Company Announcements
PolyPid Advances Phase 3 Trial and Secures Financing
4M ago
6K
PYPD
PolyPid price target lowered to $11 from $14 at H.C. Wainwright
Premium
The Fly
PolyPid price target lowered to $11 from $14 at H.C. Wainwright
4M ago
PYPD
PolyPid announces DSMB recommendation to continue Phase 3 D-PLEX study
PremiumThe Fly
PolyPid announces DSMB recommendation to continue Phase 3 D-PLEX study
4M ago
PYPD
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
PremiumCompany Announcements
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
4M ago
6K
PYPD
PolyPid announces research, development collaboration with ImmunoGenesis
PremiumThe Fly
PolyPid announces research, development collaboration with ImmunoGenesis
4M ago
PYPD
PolyPid Faces Nasdaq Non-Compliance Challenge
PremiumCompany Announcements
PolyPid Faces Nasdaq Non-Compliance Challenge
4M ago
6K
PYPD
PolyPid receives noncompliance notification from Nasdaq
PremiumThe FlyPolyPid receives noncompliance notification from Nasdaq
4M ago
PYPD
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
Premium
Company Announcements
PolyPid Reports Q3 Results Amid SHIELD II Trial Progress
5M ago
PYPD
PolyPid Announces SHIELD II Trial Progress and Financials
Premium
Company Announcements
PolyPid Announces SHIELD II Trial Progress and Financials
5M ago
6K
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >